NSE filing, NSE: MAHLIFE. Summary written from the filing by ALFA Finder's alert engine.
Mahindra Lifespace Developers Ltd: key numbers
- Share price
- ₹310.70
- Market cap
- ₹6,631 Cr
- Revenue (annual)
- ₹1,178 Cr
- Net profit (annual)
- ₹298.1 Cr
- P/E (TTM)
- 22.0×Sector 33.7×
- Promoter holding
- 52.40%-0.01% QoQ
- FII holding
- 7.35%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Mahindra Lifespace Developers Ltd
All →Mahindra Lifespace Developers Capacity Expansion
Mahindra Lifespaces announced development of a 10.05-acre North Bengaluru parcel with 1 million sq. ft. saleable area. Estimated GDV is ₹1,250 crore; launch expected within nine months.
- saleable area
- 1000000 sq. ft.
Mahindra Lifespace Developers Results Correction
Mahindra Lifespace clarified a clerical error in the auditor's review report naming subsidiary Mahindra Sakura Developers Private Limited. The correction concerns only the entity name, with no financial figures changed.
Mahindra Lifespace Developers Management Change
Mahindra Lifespace Developers Limited announced the resignation of Ms. Parveen Mahtani from the position of Chief Legal Officer, effective October 28, 2026.
Mahindra Lifespace Developers Employee Stock Options
Mahindra Lifespace Developers allotted equity shares under its Employee Stock Option Scheme (ESOS). This routine allotment follows the exercise of options by eligible employees.
Mahindra Lifespace Developers Investor Presentation: Key Takeaways
Mahindra Lifespaces delivered strong Q2 FY27 performance with residential pre-sales of Rs 1,063 Cr and PAT of Rs 16 Cr. Strategic focus remains on scaling to 10K Cr sales by FY30.
- Call
- Guides 500% growth
Mahindra Lifespace Developers Q2 FY27 Results: Net Profit ₹16.3 Cr, Down 66.0% YoY
Mahindra Lifespace Developers Ltd reported revenue from operations of ₹32.4 Cr (+84.1% YoY) and net profit of ₹16.3 Cr (-66.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹16.3 Cr · -66.0% YoY
Other employee stock options announcements
All →RateGain Travel Technologies Employee Stock Options
RateGain granted 53,021 Stock Appreciation Rights under its SAR Scheme 2022 at ₹800 and ₹862.25 per unit. The grants vest over four years and are exercisable within three years of vesting.
- Execution
- Vesting over 4 years (10% Y1, 20% Y2, 30% Y3, 40% Y4); exercisable within 3 years of vesting
Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.